LACTB and urinary bladder cancer: Similarly, in bladder cancer, LACTB modulates ferroptosis and mitochondrial function by inducing erastin-mediated ferroptosis, which exacerbates mitochondrial dysfunction and ROS production (Figure 3), counteracting the ferroptosis-inhibitory effects of PCBP1.